{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T06:26:27Z","timestamp":1763619987031},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,7,10]],"date-time":"2013-07-10T00:00:00Z","timestamp":1373414400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s11060-013-1203-6","type":"journal-article","created":{"date-parts":[[2013,7,9]],"date-time":"2013-07-09T17:05:03Z","timestamp":1373389503000},"page":"113-117","source":"Crossref","is-referenced-by-count":5,"title":["Platinum compounds and sodium metabolism in children with diencephalic glioma"],"prefix":"10.1007","volume":"115","author":[{"given":"N.","family":"Puma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ruggiero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Scalzone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Coccia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Triarico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Trombatore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Mastrangelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Riccardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,7,10]]},"reference":[{"issue":"5","key":"1203_CR1","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.3171\/FOC-07\/11\/E2","volume":"23","author":"MJ Binning","year":"2007","unstructured":"Binning MJ, Liu JK, Kestle JRW, Brockmeyer DL, Walker ML (2007) Optic pathway gliomas: a review. Neurosurg Focus 23(5):E2","journal-title":"Neurosurg Focus"},{"key":"1203_CR2","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3171\/jns.1997.86.5.0747","volume":"86","author":"RJ Packer","year":"1997","unstructured":"Packer RJ, Ater J, Allen J, Phillips P, Geyer R, Nicholson HS, Jakacki R, Kurczynski E, Needle M, Finlay J, Reaman G, Boyett JM (1997) Carboplatin and vincristine chemotherapy for children with newly diagnosed progression of low-grade gliomas. J Neurosurg 86:747\u2013754","journal-title":"J Neurosurg"},{"key":"1203_CR3","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0360-3016(01)01705-9","volume":"51","author":"BJ Fisher","year":"2001","unstructured":"Fisher BJ, Leighton CC, Vujovic O, Macdonald DR, Stitt L (2001) Results of a policy of surveillance after surgical management of pediatric low-grade gliomas. Int J Radiat Oncol Biol Phys 51:704\u2013710","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1203_CR4","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0889-8529(18)30192-0","volume":"21","author":"L Kovacs","year":"1992","unstructured":"Kovacs L, Robertson G (1992) Syndrome of inappropriate antidiuresis. Endocrinol Metab Clin North Am 21:859\u2013875","journal-title":"Endocrinol Metab Clin North Am"},{"key":"1203_CR5","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0889-8529(18)30174-9","volume":"22","author":"C Buonocore","year":"1993","unstructured":"Buonocore C, Rosinson A (1993) The diagnosis and management of diabetes insipidus during medical emergencies. Endocrinol Metab Clin North Am 22:411\u2013423","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"10","key":"1203_CR6","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/01.mph.0000141348.62532.73","volume":"26","author":"P Bertolini","year":"2004","unstructured":"Bertolini P, Lassalle M, Mercier G, Raquin MA, Izzi G, Corradini N, Hartmann O (2004) Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss. J Pediatr Oncol 26(10):649\u2013655","journal-title":"J Pediatr Oncol"},{"issue":"6","key":"1203_CR7","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00280-008-0711-0","volume":"61","author":"V Launay-Vacher","year":"2008","unstructured":"Launay-Vacher V, Rey JB, Isnard-Bagnis C, Deray G, Daouphars M, European Society of Clinical Pharmacy Special Interest Group on Cancer Care (2008) Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care. Cancer Chemother Pharmacol 61(6):903\u2013909","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"1203_CR8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/MAJ.0b013e31812dfe1e","volume":"334","author":"X Yao","year":"2007","unstructured":"Yao X, Panichpisal K, Kurtzman N, Nugent K (2007) Cisplatin nephrotoxicity: a review. Am J Med Sci 334(2):115\u2013124","journal-title":"Am J Med Sci"},{"issue":"10","key":"1203_CR9","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/S0959-8049(98)00224-X","volume":"34","author":"D Lebwohl","year":"1998","unstructured":"Lebwohl D, Canetta R (1998) Clinical development of platinum complexes in cancer therapy: an historical perspective and an update. Eur J Cancer 34(10):1522\u20131534","journal-title":"Eur J Cancer"},{"issue":"4","key":"1203_CR10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/00003495-200059004-00003","volume":"59","author":"PJ O\u2019Dwyer","year":"2000","unstructured":"O\u2019Dwyer PJ, Stevenson JP, Johnson SW (2000) Clinical pharmacokinetics and administration of established platinum drugs. Drugs 59(4):19\u201327","journal-title":"Drugs"},{"key":"1203_CR11","doi-asserted-by":"crossref","first-page":"e938","DOI":"10.1542\/peds.2009-1597","volume":"125","author":"S Grewal","year":"2010","unstructured":"Grewal S, Merchant T, Reymond R, McInerney M, Hodge C, Shearer P (2010) Auditory late effects of childhood cancer therapy: a report from the children\u2019s oncology group. Pediatrics 125:e938","journal-title":"Pediatrics"},{"key":"1203_CR12","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/ng.478","volume":"41","author":"CJ Ross","year":"2009","unstructured":"Ross CJ, Katzov-Eckert H, Dub\u00e9 MP, Brooks B, Rassekh SR, Barhdadi A, Feroz-Zada Y, Visscher H, Brown AM, Rieder MJ, Rogers PC, Phillips MS, Carleton BC, Hayden MR, CPNDS Consortium (2009) Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy. Nat Genet 41:1345\u20131349","journal-title":"Nat Genet"},{"issue":"18","key":"1203_CR13","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1016\/j.ejca.2009.06.032","volume":"45","author":"R Skinner","year":"2009","unstructured":"Skinner R, Parry A, Price L, Cole M, Craft AW, Pearson AD (2009) Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: relevance of age and dose as risk factors. Eur J Cancer 45(18):3213\u20133229","journal-title":"Eur J Cancer"},{"issue":"6","key":"1203_CR14","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/pbc.21695","volume":"51","author":"DP Jones","year":"2008","unstructured":"Jones DP, Spunt SL, Green D, Springate JE, Children\u2019s Oncology Group (2008) Renal late effects in patients treated for cancer in childhood: a report from the Children\u2019s Oncology Group. Pediatr Blood Cancer 51(6):724\u2013731","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"1203_CR15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/bjc.1986.147","volume":"54","author":"JC Willox","year":"1986","unstructured":"Willox JC, McAllister EJ, Sangster G, Kaye SB (1986) Effects of magnesium supplementation in testicular cancer patients receiving cis-platin: a randomised trial. Br J Cancer 54(1):19\u201323","journal-title":"Br J Cancer"},{"key":"1203_CR16","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1681\/ASN.V125875","volume":"12","author":"SW Kim","year":"2001","unstructured":"Kim SW, Lee JU, Nah MY, Kang DG, Ahn KY, Lee HS, Choi KC (2001) Cisplatin decreases the abundance of aquaporin water channels in rat kidney. J Am Soc Nephrol 12:875\u2013882","journal-title":"J Am Soc Nephrol"},{"key":"1203_CR17","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s11060-009-0033-z","volume":"97","author":"S Afzal","year":"2010","unstructured":"Afzal S, Wherrett D, Bartels U, Tabori U, Huang A, Stephens D, Bouffet E (2010) Challenges in management of patients with intracranial germ cell tumor and diabetes insipidus treated with cisplatin and\/or ifosfamide based chemotherapy. J Neurooncol 97:393\u2013399","journal-title":"J Neurooncol"},{"key":"1203_CR18","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1002\/1097-0142(19941101)74:9<2589::AID-CNCR2820740929>3.0.CO;2-6","volume":"74","author":"WP Bryant","year":"1994","unstructured":"Bryant WP, O\u2019Marcaigh AS, Ledger GA, Zimmerman D (1994) Aqueous vasopressin infusion during chemotherapy in patients with diabetes insipidus. Cancer 74:2589\u20132592","journal-title":"Cancer"},{"key":"1203_CR19","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/pbc.20026","volume":"43","author":"SJ Kellie","year":"2004","unstructured":"Kellie SJ, Boyce H, Dunkel IJ, Diez B, Rosenblum M, Brualdi L, Finlay JL (2004) Intensive cisplatin and cyclophosphamide-based chemotherapy without radiotherapy for intracranial germinomas: failure of a primary chemotherapy approach. Pediatr Blood Cancer 43:126\u2013133","journal-title":"Pediatr Blood Cancer"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-013-1203-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-013-1203-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-013-1203-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,27]],"date-time":"2022-02-27T23:39:41Z","timestamp":1646005181000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-013-1203-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,10]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["1203"],"URL":"https:\/\/doi.org\/10.1007\/s11060-013-1203-6","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,10]]}}}